CROI 2017 Program and Information

Program and Agenda

482 HIV PRETREATMENT DRUG RESISTANCE IN CAMEROON: FIRST NATIONWIDE STUDY Gaëlle F. Tchouwa 1 , Jenny Domyeum 1 , Sabrina Eymard-Duvernay 2 , Amandine Cournil 2 , Eric Delaporte 2 , Martine Peeters 2 , Elliot Raizes 3 , Eitel Mpoudi-Ngole 1 , Avelin F. Aghokeng 4 1 CREMER, Yaoundé, Cameroon, 2 Univ de Montpellier, Montpellier, France, Montpellier, France, 3 CDC, Atlanta, GA, USA, 4 IRD, Yaoundé, Cameroon 483 LOWPREVALENCE OF HIV DRUG RESISTANCEWITHMODERN AGENTS Thibaut Davy , Laurence Brunet, Sonia Napravnik, Oksana Zakharova, Ann M. Dennis, Joseph J. Eron Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA 484 LOWPREVALENCE OF NRTI, NNRTI, AND PI DRUG RESISTANCE MUTATIONS IN BOTSWANA Sikhulile Moyo 1 , Simani Gaseitsiwe 1 , Melissa Zahralban-Steele 2 , Dorcas Maruapula 1 , Phillimon P. Sebogodi 1 , Madisa Mine 3 , Elliot Raizes 4 , Shahin Lockman 2 , Max Essex 2 , Vlad Novitsky 2 1 Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana, 2 Harvard Univ, Boston, MA, 3 Natl Hlth Lab, Gaborone, Botswana, 4 CDC, Atlanta, GA, USA 485 ARV RESISTANCEMUTATIONS IN PATIENTS RECEIVING AWHO TDF-CONTAINING 1ST-LINE REGIMEN Soo-Yon Rhee 1 , John Gregson 2 , Ravindra K. Gupta 3 , Robert Shafer 1 , for the TenoRes Study Group 1 Stanford Univ, Stanford, CA, USA, 2 London Sch of Hygiene and Trop Med, London, UK, 3 Univ Coll London, London, UK 486 VIRAL SUPPRESSION AND ACQUIRED HIV DRUG RESISTANCE IN CAMEROON: A NATIONWIDE STUDY Gaëlle F. Tchouwa 1 , Jenny Domyeum 1 , Sabrina Eymard-Duvernay 2 , Amandine Cournil 2 , Eric Delaporte 2 , Martine Peeters 2 , Eitel Mpoudi-Ngole 1 , Elliot Raizes 3 , Avelin F. Aghokeng 4 1 CREMER, Yaoundé, Cameroon, 2 Univ de Montpellier, Montpellier, France, 3 CDC, Atlanta, GA, USA, 4 IRD, Yaoundé, Cameroon 487 HIGHHIV DRUG RESISTANCE OF FIRST-LINE ART TREATMENT IN BENIN PEDIATRIC POPULATION Djeneba Bocar Fofana 1 , Marcelline d’Almeida 2 , Pierre-Marie Girard 1 , Bernabé Lafia 3 , Sidonie Lambert 1 , Lutecia Zohoun-Guidigbi 2 , Rene Keke 4 , Cathia Soulie 5 , Anne-Geneviève Marcelin 5 , Laurence Morand-Joubert 1 1 Saint-Antoine Hosp, Paris, France, 2 Univ d’Abomey–Calavi, Benin, 3 CNHU– HKM, Cotonou, Benin, 4 Reference Lab of the Natl Cntr for the Treatment of HIV, Cotonou, Benin, 5 Pitie-Salpetriere Hosp, Paris, France 488 DRUG-RESISTANT HIV-1 DURING LONG-TERMSECOND-LINE ANTIRETROVIRAL TREATMENT IN KENYA Seth Inzaule 1 , Raph L. Hamers 1 , Irene Mukui 2 , Kennedy Were 3 , Preston Owiti 3 , Daniel Kwaro 3 , Tobias R. de Wit 1 , Clement Zeh 4 1 Academic Med Cntr of the Univ of Amsterdam, Amsterdam, Netherlands, 2 Natl AIDS and STI Control Prog, Nairobi, Kenya, 3 Kenya Med Rsr Inst, Kisumu, Kenya, 4 US CDC, Kisumu, Kenya 489 ELIMINATING DRUG RESISTANCE IN SOUTH AFRICA BY USING DOLUTEGRAVIR Katie Sharp 1 , Thibault Mesplede 2 , Mark A. Wainberg 2 , Sally Blower 1 1 Univ of California Los Angeles, Los Angeles, CA, USA, 2 McGill Univ, Montreal, Quebec, Canada

Poster Sessions • Thursday

CROI 2017 182